Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

cardiac

Cannes Lion 2022

Our Top 5 Pharma Picks From Cannes Lions

Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022.

The Good Ideas Group

- PMLiVE

Abbott’s wearable glucose monitor to be available across England

FreeStyle Libre will be prescribed to those with T1 diabetes

- PMLiVE

AbbVie’s uterine fibroids drug aces second phase III trial

An FDA verdict is expected in the US in the coming weeks

- PMLiVE

Abbott launches Bluetooth cardiac monitor Confirm RX in the US

The device sits under the patient’s skin and connects to the firm's myMerlin app

Deal Watch September 2016

Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up

- PMLiVE

Abbott diabetes sensor wins European CE mark

FreeStyle Libre system gains kitemark

- PMLiVE

AZ links with Abbott on personalised asthma diagnostic

Diagnostic would aim to identify patients most likely to respond to tralokinumab

- PMLiVE

Mylan buys Abbott’s non-US generics in $5.3bn deal

Lower tax rate drives bid to create new firm based in Netherlands

- PMLiVE

Abbott offers up to $495m for Russia’s Veropharm

Acquisition will add to its generics portfolio

- PMLiVE

Abbott strikes $3.3bn Latin America generics deal

Boosts portfolio in region with acquisition of CFR Pharmaceuticals

- PMLiVE

AbbVie sales jump on strong Humira gains

Extra indications help boost performance of treatment for autoimmune disorders

- PMLiVE

Abbott and GSK announce job cuts in Ireland

Nearly 300 positions to go in Cork and Tipperary

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links